Home › Kidney Cancer › Florida › Miami
Kidney Cancer clinical trials in Miami, FL
6 studies for Kidney Cancer are looking for participants at sites in and around Miami (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors
RecruitingPhase 1
- Research Site, Miami
Open-Label Phase 1/2 Study of NEO-811 in Subjects With Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell Carcinoma
RecruitingPhase 1
- NEO-811 Florida Site, Miami
Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma
RecruitingPhase 3
- Research Site, Miami
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
RecruitingPhase 1/2
- Sylvester Comprehensive Cancer Center - University of Miami Health System, Miami
A Study of VET3-TGI in Patients With Solid Tumors
RecruitingPhase 1
- University of Miami, Miami
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecruitingObservational study
- Massive Bio SYNERGY-AI site, Miami
About Kidney Cancer
Kidney cancer symptoms are hard to detect at first but they do exist. Read more about the top 5 symptoms and the treatment options available
More about Kidney Cancer on MedlinePlus
Kidney Cancer trials in other cities
- New York City, NY16 studies
- Boston, MA11 studies
- Nashville, TN11 studies
- Houston, TX10 studies
- St. Louis, MO10 studies
- Edison, NJ9 studies
- Dallas, TX9 studies
- Washington, DC9 studies
- San Diego, CA9 studies
- Los Angeles, CA8 studies
- Seattle, WA8 studies
- Queens, NY7 studies
Other studies in Miami
- Breast Cancer42 studies
- Cancer (all types)36 studies
- Non-Small Cell Lung Cancer35 studies
- Prostate Cancer30 studies
- Obesity28 studies
- Ovarian Cancer24 studies
- Acute Myeloid Leukemia24 studies
- Overweight23 studies
- Metastatic Cancer22 studies
- Multiple Myeloma22 studies
- Lung Cancer22 studies
- Alzheimer's Disease21 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.